Send to a Friend Font Size: Increase Decrease

Broadfin Capital

Broadfin Capital's Portfolio

Ticker	# of Shares	Price	Value
	5,574,366	$195.32	$1,088,785,168
	2,707,851	$195.32	$528,897,458
	2,000,000	$195.32	$390,640,000
	1,839,372	$195.32	$359,266,140
SPY	440,000	$672.38	$295,847,200
	1,236,368	$195.32	$241,487,398
	1,029,012	$195.32	$200,986,624
IWM	800,000	$250.89	$200,712,000
	1,003,099	$195.32	$195,925,297
	721,073	$195.32	$140,839,979
View Additional Portfolio Information »

Broadfin Capital

Login to help us fill in information about this entity.

Form SC 13G/A RedHill Biopharma Ltd. Filed by: Broadfin Capital, LLC Feb 10, 2017 04:09PM

RedHill Biopharma Reports 2015 Fourth Quarter and Full-Year Financial Results Feb 25, 2016 08:00AM

Form SC 13G/A RedHill Biopharma Ltd. Filed by: Broadfin Capital, LLC Feb 12, 2016 06:04AM

RedHill Biopharma Reports Results for the Third Quarter of 2015 Nov 9, 2015 07:00AM

RedHill Biopharma Reports Results for the Second Quarter of 2015 Jul 29, 2015 06:05AM

Jul 22, 2015 10:10AM RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares
Apr 30, 2015 07:00AM RedHill Biopharma Reports Results for the First Quarter of 2015
Feb 26, 2015 04:00PM Form SC 13G RedHill Biopharma Ltd. Filed by: Broadfin Capital, LLC